HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Active site specificity of plasmepsin II.

Abstract
Members of the aspartic proteinase family of enzymes have very similar three-dimensional structures and catalytic mechanisms. Each, however, has unique substrate specificity. These distinctions arise from variations in amino acid residues that line the active site subsites and interact with the side chains of the amino acids of the peptides that bind to the active site. To understand the unique binding preferences of plasmepsin II, an enzyme of the aspartic proteinase class from the malaria parasite, Plasmodium falciparum, chromogenic octapeptides having systematic substitutions at various positions in the sequence were analyzed. This enabled the design of new, improved substrates for this enzyme (Lys-Pro-Ile-Leu-Phe*Nph-Ala/Glu-Leu-Lys, where * indicates the cleavage point). Additionally, the crystal structure of plasmepsin II was analyzed to explain the binding characteristics. Specific amino acids (Met13, Ser77, and Ile287) that were suspected of contributing to active site binding and specificity were chosen for site-directed mutagenesis experiments. The Met13Glu and Ile287Glu single mutants and the Met13Glu/Ile287Glu double mutant gain the ability to cleave substrates containing Lys residues.
AuthorsJ Westling, P Cipullo, S H Hung, H Saft, J B Dame, B M Dunn
JournalProtein science : a publication of the Protein Society (Protein Sci) Vol. 8 Issue 10 Pg. 2001-9 (Oct 1999) ISSN: 0961-8368 [Print] United States
PMID10548045 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Hemoglobins
  • Protozoan Proteins
  • Aspartic Acid Endopeptidases
  • plasmepsin II
Topics
  • Aspartic Acid Endopeptidases (chemistry, genetics, metabolism)
  • Binding Sites
  • Hemoglobins (chemistry)
  • Kinetics
  • Mutagenesis, Site-Directed
  • Protein Conformation
  • Protozoan Proteins
  • Substrate Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: